1 unchanged sentence
Rule 10b5-1 and non-Rule 10b5-1 trading arrangements
−Removed: During the fiscal quarter ended September 30, 2024, none of our directors or officers informed us of the adoption, modification or termination of a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as those terms are defined in Regulation S-K, Item 408.
+Added: On March 10, 2025 , George W.
+Added: LeMaitre , Chairman and Chief Executive Officer , adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 250,000 shares of the Company’s common stock until March 10, 2027.
Incorporated by Reference
Exhibit Description
−Removed: Amended and Restated By-laws of the Registrant
−Removed: Second Amended and Restated Certificate of Incorporation of the Registrant
−Removed: Amendment to Second Amended and Restated Certificate of Incorporation of the Registrant
−Removed: LeMaitre Vascular, Inc.
−Removed: Fourth Amendment and Restated 2006 Stock Option and Incentive Plan
Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15 d-14(a).
9 unchanged sentences
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
−Removed: Indicates a management contract or any compensatory plan, contract, or arrangement.
−Removed: The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Quarterly Report on Form 10-Q, are not deemed filed with the SEC and are not to be incorporated by reference into any filing of LeMaitre Vascular, Inc.
−Removed: under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 8, 2024.
+Added: This certification will not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section.
+Added: Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on May 8, 2025.
LEMAITRE VASCULAR, INC.
1 unchanged sentence
Chairman and Chief Executive Officer
−Removed: /s/ Joseph P.
−Removed: Pellegrino, Jr.
−Removed: Pellegrino, Jr.
−Removed: Chief Financial Officer and Director
+Added: /s/ Dorian LeBlanc
+Added: Dorian LeBlanc
+Added: Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.